Olmesartan Medoxomil Patent Expiration
Olmesartan Medoxomil is Used for lowering high blood pressure. It was first introduced by Cosette Pharmaceuticals Inc
Olmesartan Medoxomil Patents
Given below is the list of patents protecting Olmesartan Medoxomil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Benicar |
US6878703 (Pediatric) | Pharmaceutical composition |
May 19, 2022
(Expired) | Cosette |
| Benicar | US6878703 | Pharmaceutical composition |
Nov 19, 2021
(Expired) | Cosette |
| Benicar |
US5616599 (Pediatric) | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Oct 25, 2016
(Expired) | Cosette |
| Benicar | US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Apr 25, 2016
(Expired) | Cosette |
Olmesartan Medoxomil's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List